Objectively identified comorbidities in COPD: impact on pulmonary rehabilitation outcomes

Pulmonary rehabilitation (PR) is a comprehensive intervention recognised as a core component in the treatment of patients with chronic obstructive pulmonary disease (COPD) [1]. Comorbidities are highly prevalent in patients with COPD entering PR [2–4], which may be associated with the change in exercise performance and health status after PR [3–5]. Nonetheless, previous studies used self-reported and/or chart-based comorbidities, and only the impact of individual comorbidities or arbitrarily grouped comorbidities were studied [3, 4]. Patients with COPD and multiple comorbidities can still benefit from pulmonary rehabilitation http://ow.ly/LXAWc

[1]  N. Ambrosino,et al.  A Prospective Multicentric Study of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease and Different Clinical Phenotypes , 2015, Respiration.

[2]  Thierry Troosters,et al.  An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease , 2014, European Respiratory Journal.

[3]  Thierry Troosters,et al.  An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. , 2013, American journal of respiratory and critical care medicine.

[4]  Martijn A Spruit,et al.  Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.

[5]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[6]  Mark A Williams,et al.  Aerobic Exercise Intensity Assessment and Prescription in Cardiac Rehabilitation: A JOINT POSITION STATEMENT OF THE EUROPEAN ASSOCIATION FOR CARDIOVASCULAR PREVENTION AND REHABILITATION, THE AMERICAN ASSOCIATION OF CARDIOVASCULAR AND PULMONARY REHABILITATION, AND THE CANADIAN ASSOCIATION OF CARDIAC , 2012, Journal of cardiopulmonary rehabilitation and prevention.

[7]  C. Boreham,et al.  Exercise Prescription in the Treatment of Type 2 Diabetes Mellitus , 2012, Sports Medicine.

[8]  A. von Leupoldt,et al.  The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. , 2011, Chest.

[9]  L. Fabbri,et al.  Efficacy of standard rehabilitation in COPD outpatients with comorbidities , 2010, European Respiratory Journal.

[10]  S. Borson,et al.  Anxiety and depression in COPD: Current understanding, unanswered questions, and research needs. , 2009, Revista portuguesa de pneumologia.

[11]  L. Fabbri,et al.  Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation , 2008, Thorax.

[12]  Martijn A Spruit,et al.  Integration of pulmonary rehabilitation in COPD , 2008, The Lancet.

[13]  Y. Lacasse,et al.  Assessing the impact of pulmonary rehabilitation on functional status in COPD , 2007, Thorax.

[14]  P. Jones.  St. George's Respiratory Questionnaire: MCID , 2005, COPD.

[15]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.